Invention Grant
US07696206B2 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
有权
2-苯基取代的咪唑并三嗪酮作为磷酸二酯酶抑制剂
- Patent Title: 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
- Patent Title (中): 2-苯基取代的咪唑并三嗪酮作为磷酸二酯酶抑制剂
-
Application No.: US12569720Application Date: 2009-09-29
-
Publication No.: US07696206B2Publication Date: 2010-04-13
- Inventor: Ulrich Niewöhner , Mazen Es-Sayed , Helmut Haning , Thomas Schenke , Karl-Heinz Schlemmer , Jorg Keldenich , Erwin Bischoff , Elisabeth Perzborn , Klaus Dembowsky , Peter Serno , Marc Nowakowski
- Applicant: Ulrich Niewöhner , Maria Niewöhner, legal representative , Mazen Es-Sayed , Helmut Haning , Thomas Schenke , Karl-Heinz Schlemmer , Jorg Keldenich , Erwin Bischoff , Elisabeth Perzborn , Klaus Dembowsky , Peter Serno , Marc Nowakowski
- Applicant Address: DE Berlin
- Assignee: Bayer Schering Pharma Aktiengesellschaft
- Current Assignee: Bayer Schering Pharma Aktiengesellschaft
- Current Assignee Address: DE Berlin
- Agency: Edwards Angell Palmer & Dodge LLP
- Agent Ralph A. Loren; Nicholas J. DiCeglie, Jr.
- Priority: DE19750085 19971112; DE19812462 19980323; DE19840289 19980904
- Main IPC: C07D403/12
- IPC: C07D403/12 ; A61K31/53 ; A61P15/10
Abstract:
The application claims a compound of the formula or a salt, a hydrate, or a hydrate of a salt thereof. The compounds inhibit cGMP-metabolizing phosphodiesterases and are suitable for use as active compounds in pharmaceuticals, for the treatment of erectile dysfunction.
Public/Granted literature
- US20100016323A1 2-PHENYL SUBSTITUTED IMIDAZOTRIAZINONES AS PHOSPHODIESTERASE INHIBITORS Public/Granted day:2010-01-21
Information query
